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Relationship of Anger Trait and Anger Expression to
C-Reactive Protein in Post-Menopausal Women
Rosalyn Gross
ABSTRACT
Coronary heart disease is the leading cause of death in American
women, accounting for one in six deaths in 2004. One third of women
over the age of forty will develop coronary heart disease in their
lifetime. The role of chronic and excessive inflammation and risk
factors, such as smoking and high cholesterol, are now wellestablished factors contributing to coronary heart disease pathology. A
knowledge gap exists in that little is known about the mechanisms by
which psychosocial factors, such as anger, may be associated with
pro-inflammatory processes that contribute to cardiovascular morbidity
and mortality in women. The purpose of this study was to determine if
there were differences in serum levels of the proinflammatory
biomarker, C-reactive protein, in post-menopausal women who scored
high on anger characteristics compared to those with low anger
characteristics. Mean levels of C-reactive protein were not found to be
different in a sample of 42 women with high trait anger or high anger
expression compared to those with low trait anger or low anger
expression. Significant relationships were found in C-reactive protein
v

and some anger control characteristics (anger control-in) and might
imply that certain anger expression styles may play a role in proinflammatory responses in post-menopausal women.
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Chapter One: Introduction to the Study
Statement of the Problem
Cardiovascular disease is the leading cause of mortality in American
women with coronary heart disease (CHD) responsible for 50% of deaths in
2004. One third of women over the age of 40 will develop coronary heart disease
in their lifetime (Rosamond et al., 2007). Two-thirds of women who experience
sudden death from CHD had no previous symptoms of their illness (Wenger,
2004). Chronic and excessive inflammation and risk factors such as smoking and
hypercholesterolemia, are now well-established factors contributing to CHD
pathology. However, little is known about the mechanisms by which psychosocial
factors, such as anger, may be associated with proinflammatory processes that
play a role in cardiovascular morbidity and mortality in women.
Background and Significance
Anger is a universal powerful and generally negative emotion that is
expressed throughout the lifespan and is associated with enhanced vascular
tone, elevated heart rate, and elevated blood pressure responses, similar to
those elicited by the fear response (Bongard, Pfeiffer, Al-Absi, Hodapp, &
Linnenekember, 1997). Anger has been associated with angina, myocardial
infarction, and sudden cardiac death (Kop, 1999; Stuart-Shor, Buselli, & Carroll,
2003) as a result of direct acute and indirect chronic biological processes. These
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include cardiovascular reactivity (CVR), which is an increased heart rate and
blood pressure in response to stress, stress-induced hypertension (Abel, Larkin,
& Edins, 1995), carotid atherosclerosis (Matthews, Owens, Kuller, Sutton-Tyrrell,
& Jansen-McWilliams, 1998; Troxel, Matthews, Bromberger, & Sutton-Tyrell,
2003), existing CHD, (Linfante, Allan, Smith, & Mosca, 2003), incident heart
disease (Gallacher, Yarnell, Sweetnam, Elwood, & Stansfeld, 1999), and
metabolic syndrome (Raikkonen, Matthews, & Kuller, 2001).
Current theories regarding mechanisms for the potential relationship of
CHD to dysphoric emotional states and traits, such as anger, date back to the
early 20th century and are based on the association of a recurrent pattern of an
exaggerated sympathetic nervous system response. Alexander (1939) first
proposed that anger contributed to the development of sustained elevated blood
pressure because of chronic activation of the autonomic and cardiovascular
systems. Alexander’s theory led to the identification by Dunbar (1943) of the
“coronary prone personality” that subsequently formed the now famous
designation of the Type A behavior pattern and especially the harmful angerhostility personality component (Spielberger et al., 1985). Research investigating
anger, specifically trait anger (anger proneness), emerged in the 70s and 80s,
when researchers began to explore physiological reactivity relationships and
personality characteristics (Schum, Jorgensen, Verhaeghen, Sauro, &
Thibodeau, 2003).
Many large prospective designs have examined the significant role that
anger and hostility have on CVR and CHD. The majority of these studies suggest
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that anger directly or indirectly predisposes individuals to heightened CVR, which
may lead to increased risk of development of hypertension and heart disease
(Eng, Fitzmaurice, Kubzansky, Rimm, & Kawachi, 2003; Everson, Goldberg,
Kaplan, Julkunen, & Salonen, 1998; Everson-Rose & Lewis, 2005; Fichera &
Andreassi, 1998; Julkunen & Ahlstrom, 2006; Lovallo & Gerin, 2003; Swartz,
Gerin, Davidson, Pickering, Phil, Brosschot, et al., 2003; Thomas, 1997).
As research continued to reveal the complex interrelationships of the
mind-body connection and cardiovascular disease Kawachi, Sparrow, Spiro,
Vokonas, and Weiss (1996) proposed a biopsychosocial model of anger
interactions that promote CHD as a result of the direct biological effects of
elevated catecholamines, increased myocardial oxygen demand, vasospasm,
and increased platelet aggregability. Pro-inflammatory cytokines, specifically
interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF!)
have been identified and found to be increased in systemic inflammation and
recognized as risk factors for poor health outcomes associated with cardiac
disease, diabetes mellitus, and osteoporosis (Segerstrom & Miller, 2004).
TNF! has been found to alter endothelial cell function and promote the
expression of adhesion molecules that contribute to accumulation of cellular
debris and also promote the production of C-reactive protein (CRP) (Suarez,
Lewis, & Kuhn, 2002). CRP, a well-established marker for CHD risk, is an acute
phase reactive protein that is triggered by the release of pro-inflammatory
cytokines, particularly IL-6, and also appears to play a role in the development of
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atherogenesis and subsequent CHD (Hapuarachchi, Chalmers, Winefield, &
Blake-Mortimer, 2003).
Finally, new evidence shows that chronic activation of the stress response
with subsequent persistent release of glucocorticoid hormones and
catecholamines, may also dysregulate immune function (Padgett & Glaser, 2003)
including primary and secondary antibody responses (Vedhara, Fox, & Wang,
2005). Because the effects of stressors differ over time and between individuals,
the nature of the stressor, its contextual meaning, and host differences likely
determine the degree to which stress reactions produce immune changes
(Segerstrom, Kemeny, & Laudenslager, 2001). Current researchers studying
psychoneuroimmunology (PNI) hypothesize that chronic stress and stressful
emotions, like anger and anxiety, elicit both innate and specific immune
responses by enhancing patterns of pro-inflammatory cytokine secretion which,
in turn, activate the hypothalamic-hypophyseal-adrenocortical (HPA) axis and
stimulate the acute phase response (Black, 2006; Black & Garbutt, 2002;
Bryndon, Magid, & Steptoe, 2005; Lovallo & Gerin, 2003; Padgett & Glasser,
2003; Segerstrom, Kemeny, & Laudenslager, 2001) and produce a variety of
sickness behaviors, such as depression and anxiety.
The emotion of anger is also very complex and involves cognitive,
affective, and behavioral aspects that are biologically and culturally based (Cox,
Stabb, & Bruckner, 1999). For women in particular, especially as a result of
Western socialization of the female gender as less powerful, the interpersonal
interactions of anger are intricately woven within the relationships of women’s
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everyday lives (Thomas, Smucker, & Droppleman, 1998). The effects of
acculturation and socialization of anger etiquette, which fosters overt displays of
anger and aggression by men generally result in women internalizing angry
feelings (Gilligan, 1982). As girls and boys grow up to be men and women,
different biobehavioral patterns are developed, especially related to
internalization and externalization of feelings. Subsequently, many women
experience dichotomous experiences of anger, whether to suppress or express
their thoughts and feelings (Cox et al.).
Trait anger, a key feature of anger, describes a relatively stable
personality trait consisting of one’s proneness to perceive situations as anger
provoking and to respond with feelings of annoyance, irritation, or fury
(Spielberger, Jacobs, Russell, Crane & Worden, 1985). High trait anger women
frequently experience angry feelings, feel others treat them unfairly, and
experience a great deal of frustration (Spielberger, 1999). Anger expression
includes angry feelings held in or suppressed (anger-in), and angry feelings that
are expressed (anger-out) (Spielberger et al.). High anger-in women frequently
experience angry emotions but control the outward expression of angry feelings,
while high anger-out women frequently express their anger by verbal or physical
aggression towards others (Spielberger).
Utilizing the theoretical framework proposed by Kawachi, Sparrow, Spiro,
Vokonas, and Weiss (1996) of the mind-body anger connection to cardiovascular
disease a conceptual model of the study is presented in Figure 1.
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Purpose of the Study
The purpose of this study was to examine differences in biobehavioral
variables in healthy post-menopausal women who were classified as high and
low in trait anger and anger expression. The specific aims of the study were to
compare differences in serum levels of CRP in high and low anger groups.
The associated research questions for this study asked:
1) Are there significant differences in mean levels of CRP in women who are
classified as high trait anger compared to those classified as low trait anger?
Directional hypothesis: High trait anger women will have higher mean levels of
CRP compared to low trait anger women.
2) Are there significant differences in mean levels of CRP in women who are
classified as high in anger expression compared to those classified as low in
anger expression?
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Directional hypothesis: Women who score high on anger expression will have
higher mean levels of CRP than those who are score low on anger expression.
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Chapter Two: Review of Literature
The study of the relationship of psychosocial factors and reactions to
emotional stressors such as anger, and immune dysregulation and inflammatory
responses has emerged within the new body of research devoted to stressneuroendocrine-immune interactions, known as PNI (Vedhara, Fox, & Wang,
1999). The impact of these interactions on health involves a multifaceted set of
signals that work in bi-directional communication among the nervous, endocrine,
and immune systems, primarily through the HPA axis and sympathetic-adrenalmedullary axis (Padgett & Glasser, 2003). Definitions of key anger terms used for
the review of literature are presented in Table 1, followed by a review of research
on cardiovascular responses to anger and a review of research on inflammatory
and immunological responses to anger.
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Table 1.
Definitions of Anger Constructs (Spielberger et al., 1985
Anger

State Anger

Trait Anger

Anger-In
Anger-Out
Anger-Control

An emotional state consisting of subjective feelings that vary
in intensity from mild annoyance or irritation to intense fury
and rage accompanied by muscular tension and arousal of
the autonomic nervous system.
A psychobiological emotional state consisting of subjective
feelings that vary in intensity from mild annoyance or
irritation to intense fury and range accompanied by muscular
tension and arousal of the autonomic nervous system.
Individual differences in anger proneness, i.e., the tendency
to perceive a wide range of situations as annoying or
frustrating, and the disposition to respond to such situations
with elevations in state anger.
Individual differences in the frequency that angry feelings
are held in or suppressed.
Individual differences in the frequency that state anger is
expressed in aggressive behavior towards other people or
objects in the environment
Individual differences in the frequency that individuals
attempt to control the outward expression of angry feelings.

Overview of Cardiovascular Responses to Anger
Briefly, psychological or emotional stress, such as anger, causes impulses
released from the cerebral cortex to transmit via the limbic system to nuclei in the
hypothalamus where corticotropin-releasing factor (CRF) and arginine
vasopressin are synthesized. CRF travels to the anterior pituitary gland that
responds by producing adrenocorticotropic hormone (ACTH) that then stimulates
the adrenal cortex to produce glucocorticosteroids. Glucocorticosteroids are
permissive to the catecholamines. Arginine vasopressin also activates secretion
of ACTH and is released by the posterior pituitary gland. Together with
norepinephrine and epinephrine produced by the sympathetic nervous system,
these chemicals constitute the major stress hormones which systemically
9

upregulate the cardiovascular system. Sympathetic nervous stimulation, sensed
by the juxtaglomerular apparatus of the kidneys, affects the renin-angiotensin
response by stimulating powerful enzymatic reactions with subsequent systemic
vasoconstriction and increased CVR (Black & Garbutt, 2002).
Enhanced sympathetic tone and increased CVR, often seen in acute
anger, has been associated with an increased risk of development of CHD and
has been correlated with increased morbidity and mortality (Abel et al., 1995;
Shapiro, Bagiella, Myers, & Gorman, 1999). However, the latest evidence reveals
that enhanced CVR may also directly contribute to the inflammatory etiology of
atherogenesis, the precursor to CHD (Lovallo & Gerin, 2003).
Overview of Inflammatory Responses to Anger
Atherogenesis begins with the development of atherosclerotic lipid-filled
macrophages, known as foam cells, which contribute to plaque formation within
the endothelial lining of the arterial blood vessels. Plaque formation initially
occurs in areas where there is increased turbulence from shear forces such as
bifurcations in carotid and coronary arteries. Macrophages, along with circulating
monocytes, add to the ongoing thickening of these plaques and the development
of new plaques through the innate immune response (Lovallo & Gerin, 2003).
The innate immune response mounts a localized inflammatory response, which
results in the release of communication molecules known as cytokines.
Cytokines are glycopeptide-signaling molecules that regulate both innate
cell-mediated immunity and humoral immunity including the acute phase
response, which provoke key steps involved in immune responses that include T-
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and B- lymphocytes, monocytes, and macrophages (Maes et al., 1998). The proinflammatory cytokines, specifically interleukins IL-1, IL-6, and TNF!, have been
identified and found to be increased in systemic inflammation and are beginning
to be recognized as biochemical markers of poor health outcomes associated
with cardiac disease, diabetes mellitus, and osteoporosis (Segerstrom & Miller,
2004). TNF! has been found to alter endothelial cell function and promote the
expression of adhesion molecules which contribute to accumulation of cellular
debris and promote the production of CRP (Suarez, Lewis, & Kuhn, 2002).
C-reactive protein is an acute phase reactive protein released by the liver
that is activated by the release of pro-inflammatory cytokines, particularly IL-6,
and appears to play a role in the development of atherogenesis and subsequent
CHD (Hapuarachchi, Chalmers, Winefield, & Blake-Mortimer, 2003). In response
to elevated levels of IL-6 following inflammation, infection, tissue injury or stress,
CRP is thought to directly activate endothelial cells to express cellular adhesion
molecules which further contribute to vascular inflammation (Gotto, 2006). Based
on large prospective studies, CRP has been shown to be a reliable biomarker of
underlying systemic inflammation and a strong predictor of future myocardial
infarction and stroke (Willerson & Ridker, 2004). Contemporary research in PNI
suggests that psychological stress-induced changes also contribute to the
increased production of pro-inflammatory cytokines and lymphocytic alterations
(Black, 2006; Black & Garbutt, 2002; Bryndon et al., 2005; Lovallo & Gerin, 2003;
Padgett & Glasser, 2003; Segerstrom et al., 2001).
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Research on Cardiovascular Reactivity Responses to Anger
The particular mechanism linking anger to CHD and hypertension remains
elusive. One leading hypothesis implicates activities of the sympathetic
adrenomedullary system and the hypothalamic-pituitary-adrenocortical axis. In
reaction to psychological stress, such as an angry emotional response, excess
stress hormones including catecholamines and corticosteroids may negatively
impact CVR by increasing platelet aggregation which leads to endothelial injury
and plaque formation triggering the surge of proinflammatory actions involved in
atherogenesis described above (Williams, Couper, Din-Dzietham, Nieto, &
Folsom, 2007).
Anger and CVR have been extensively studied and measured with various
instruments relative to risk of CHD, hypertension, and stroke; both positive and
negative associations have been found. Fontana and McLauglin (1998) used
Lazarus’ stress and coping framework to measure whether stressful situations
might predict heart rate and blood pressure and hypothesized that the more
stressful the perception of daily stressors, the higher CVR would be. Differences
in problem-focused or emotion-focused coping processes and appraisal of daily
stressors were thought to predict physiological response to stress. A small
sample of 33 college women were measured pre- and post-menstrual cycle while
performing mental arithmetic and interpersonal conflict tasks within an angerprovoking paradigm. Results demonstrated that tension reduction techniques and
positive appraisal were related to lower CVR while anger suppression increased
CVR. The researchers concluded the transactional model of stress could assist
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in generating further ideas about which psychological factors might predict CVR
(Fontana & McLauglin).
Webb and Beckstead (2002) looked at the relationship between blood
pressure, anger, coping resources, and strain. In the 90 African-American
women who were studied, women with elevated blood pressure, and women
treated for hypertension had higher anger suppression scores than normotensive
women. These findings approached statistical significance (p=.06) after
covariates (age, waist/hip ratio, and pack-year smoking history) were entered.
The clinical significance of this study may imply that anger and stress
management interventions for women with elevated blood pressure and
hypertension might be helpful in the prevention and progression of
cardiovascular disease.
The use of mental arithmetic tasks described above (Fontana &
McLauglin, 1998), challenge tasks, videogames and hostile, challenging
confederates in staged discussions have been used in a number of studies to
induce anger states while different measures of CVR were collected. Abel et al.
(1995) studied 67 female college students’ anger expression styles during video
gaming and mental arithmetic tasks while measuring heart rate and blood
pressure changes. Anger expression as measured by Spielberger’s highly
reliable Anger Expression Scale revealed that women who had moderate angerout styles had lower blood pressure responses to the arithmetic stressor than low
(p=<0.05) or high (p=0.01) anger-out women. The latter group had the highest
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reactivity to the arithmetic task compared to the moderate anger-out group
(p=0.05).
Bongard et al. (1997) used a 4-way experimental design to look at CVR
response to a mental arithmetic task. Active coping style, number reading
(nonactive coping), and anger provocation versus no provocation were compared
to reports of angry feelings. Large effect sizes (p= <0.001) were seen in
provoked participants’ heart rates, diastolic blood pressures, and angry affect.
Although the experimental design of the study was well thought out, the lack of
information including reliability and validity of the scale to measure affect limits
the applicability of findings.
Lawler et al. (1998) also used a mental arithmetic challenge and an anger
recall interview in an exploratory study to determine whether college students
with a family history of hypertension would have greater physiological responses
to anger than those without. For men, large effect sizes (p=<0.001) were found
for cardiac output and in women, for total peripheral resistance (p=<0.004). All
measures at baseline were higher in those with positive family history
(p=<0.001). Less significant correlations were found between low anger
expression, low anger experience, and high anger control with the math
challenge on all measures of CVR in those with positive family history (p=<0.10).
In another study of college women, Powch and Houston (1996) also used
confederate discussion and challenge to measure psychological variables while
subjects were provoked during blood pressure and heart rate recordings.
Relationships between cynicism, mistrust, disagreeableness, and anger-in were
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studied with the Cook-Medley Hostility Scale, State-Trait Anger Scale, and two
other less reliable instruments. High hostility was related to greater systolic blood
pressure reactivity during high interpersonal stress (p=<.001), however no
significant relationship was found to anger-in among this all white sample.
In a similar study reported by Davis, Matthews, and McGrath (2000)
college students with high hostility had significantly (p=<0.05) larger increases in
diastolic blood pressure and total peripheral resistance than low hostile
individuals when engaged in a controversial topic discussion with a confederate
who was argumentative and aggressive. Although no effect was seen on affect
response of the students as to difficulty of task, the perception of interpersonal
control varied by level of hostility. This raised the question whether low and high
hostile individuals perceive their interactions during their everyday lives in terms
of their perception of control.
Lavoie, Miller, Conway, and Fleet (2001) used a subject friendship quality
scale with physiological recordings to see if greater elevations in women’s blood
pressure, heart rate, cardiac output, stroke volume, and total peripheral
resistance would be seen in an anger-provoking situation in defense of self or
defense of their friend. Equal significant effects (p=<0.01) of anger, irritation, and
annoyance resulted whether they or their friend were harassed but only women
in the self-harass group had very significant elevations (p=<0.001) in peripheral
resistance.
Even though these six studies were conducted with college students in a
laboratory, all anger responses resulted in increased CVR and theoretically
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increased the risk for development of CHD. However, one of the questions often
raised in an analysis of studies on anger is whether simulated anger situations
cause the same physiological and psychological reactions to anger as those
experienced within every day lives of women. As noted by Brondolo et al. (2003)
individuals in a laboratory setting may use different strategies for expressing
anger than in unobserved “real life” interactions (p. 1003).
Although Thomas (1997) found no main effect for anger frequency or
intensity in blood pressure changes in a community sample of 210 women age
18 to 71, suppressed anger, especially in the home setting with spouse or best
friend, was positively related to elevated blood pressure. Thomas hypothesized
that anger suppression in women and elevations in blood pressure as a result of
interpersonal conflicts and daily stressors may be of greater significance than
blood pressure elevations related to an angry event with a stranger.
Horsten et al. (1999) asked about the association of social isolation,
depressive symptoms, anger, and heart rate variability (HRV). Using the concept
of allostasis, which proposes that physiological systems within the body fluctuate
to meet demands from external forces, they hypothesized that psychosocial
strain, as a stressor, may be related to decreased HRV in a healthy population
and an important measure of disturbed autonomic nervous system. Using a large
(n=300) random sample of healthy women, scores from the Stress Process
Questionnaire (Cronbach’s alpha=.85) and the previously validated Framingham
Anger Scale were correlated with 24-hour EKG recordings, social support
systems, and lifestyle factors. Although no effect was seen on three of the four
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anger scales, not discussing anger was associated with decreased HRV; being
married and larger household size showed a similar association. This study
demonstrated the effect of daily psychosocial strain as a possible antecedent to
CHD, especially in women who lived alone, reported lack of social support, and
did not relieve anger by talking to others.
Harris, Matthews, Sutton-Tyrell, and Lewis (2003), questioned whether
psychosocial traits are related to endothelial function. They hypothesized that
negative psychosocial characteristics may be risk factors for CHD and that
circulating estrogens and hormone replacement therapy (HRT) may be protective
in delaying declines in endothelial function. The use of the highly valid and
reliable Bortner Type A Rating Scale, Framingham Tension Scale, Beck
Depression Inventory, and Spielberger Trait Anger and Anxiety Scales revealed
that Type A behavior, anger, anxiety, and depression were significantly (p <.05)
related to impairments in endothelial function among 193 healthy
postmenopausal women. However, some of these relationships may be masked
by HRT.
Type A behavior pattern and CVR were explored by Anderson and Lawler
(1995) in a mixed methods study of 58 female students between 18 and 42 years
old. A semi-structured interview recalling an anger incident was analyzed against
blood pressure, heart rate, and classification of Type A and Type B personalities.
There was a main effect of behavior on diastolic blood pressure in Type A
women (p=<0.02) in response to frustration over autonomy needs. Type B
women had higher CVR in response to frustration over affiliation needs. Further,
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all women who suppressed anger had higher CVR than those who expressed
anger. Given the known relationship of Type A personality and CHD, chronic
anger suppression may be an additional risk factor for CHD.
Utilizing a similar framework that chronic anger suppression may
exacerbate potential or existing CHD and contribute to early mortality, Fichera
and Andreassi (1998) hypothesized that women who demonstrate high CVR to
some stressor are more likely to develop CHD. Looking at reaction time to an
oral IQ quiz, Type A women showed significant (p=<0.05) increased CVR on
both reaction time and oral quiz compared to Type B, women but the Type A high
hostile women were more reactive (p=<0.05) than Type B low hostile women.
As measured in the social milieu of the everyday lives of women, anger
suppression alone and in combination with a Type A personality may further
increase a women’s risk for CHD. Analysis of several prospective studies does
provide evidence of possible links between these variables especially in relation
to anger suppression and hostility, although many of the studies had small
numbers of women or were completed on men.
Everson, Goldberg, Kaplan, and Salonen (1998) described the
relationship between anger expression and hypertension in a four-year
prospective study of 537 men and found a large effect of anger-out (p=<0.002)
and anger-in (p=<0.01) and hypertension, increasing risk of hypertension by 12%
for every 1 point increase in either scale of anger expression. Findings from this
study could not be implied for women.
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Harburg, Julius, Naciroti, Gleiberman, and Schork (2003) utilizing the
conceptual framework that chronic suppressed anger exacerbates potential or
existing pathology and leads to mortality, prospectively .considered the landmark
Tecumseh Community Health Study to assess anger-coping styles in men and
women. Responses to hypothetical anger-provoking scenarios were examined in
relation to anger styles, blood pressure, and all cause mortality. Women showed
a significant (p=<.01) relationship between suppressed anger and risk of early
mortality for all-cause CHD, and cancer endpoints.
Similar findings were reported by Raikkonen, Matthews, and Kuller (2002).
In a large prospective study (n=425) women who had high levels of depression,
tension, and anger at baseline had elevated risk for developing metabolic
syndrome 7.4 years later (p=<.04). Further, a reciprocal relationship between
development of metabolic syndrome and increasing anger were found over time
(p=<.001). Although CVR was not measured, hypertension is one of the criteria
for metabolic syndrome.
In another large prospective study of 688 women, Rutledge et al. (2001)
also looked at cardiac related variables to determine associations between
atherosclerosis risk factors and psychological characteristics linked to CHD.
Anger expression was significantly related to dyslipidemia and larger body mass
index (BMI). A four-fold increased risk was found between high anger-out, high
levels of low-density lipoprotein (LDL), and low levels of high-density lipoprotein
(HDL). Although not measuring CVR directly, high LDL and low HDL contribute to
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the development of atherosclerosis and CHD. Therefore, the implication that
anger-out is related to the development of CHD may be made.
Troxel, Matthews, Bromberger, and Sutton-Tyrell (2003) took a random
sample (n=334) from the longitudinal Study of Women’s Health across the Nation
(SWAN) study and found significant differences in carotid artery intima thickness
in African-Americans. Looking at biobehavioral risk factors related to chronic
stress, they found combined stressors, economic hardship, and unfair treatment
(an antecedent to anger) were associated with increased subclinical carotid
artery disease over time.
Hostility, which is generally described as a more pervasive and enduring
antagonistic mental attitude (Thomas, 1993), has been extensively studied and
measured in several prospective studies of men and women (Brondolo et al.,
2003; Matthews et al., 1998; Williams et al., 2000; Williams et al., 2001). All of
these studies showed large significant effects of high trait anger, strong angry
temperament, and high trait hostility with increased CVR. In the Atherosclerosis
Risk in Community (ARIC) Study, Williams et al. (2000, 2001, 2007) showed a
twofold increased risk in CHD and threefold increase risk for CHD events and
subclinical atherosclerosis in over 13,000 men and women who were studied
over 5 years that scored high in trait anger and angry temperament. Hostility was
found to be an independent risk factor for recurrent CHD events in women from
the Heart and Estrogen Replacement (HERS) study that were followed for four
years (Chaput et al., 2002).
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Brondolo et al. (2003) wrote that the transactional model suggests that
hostility influences health partly through its effects on social relationships and
that increased CVR associated with interpersonal and other stressors may
contribute to development of CHD. However, they cautioned that the cognitive,
affective, and behavioral measurements of hostility as measured by the CookMedley Ho scale are associated in different ways to CHD and the
subcomponents of hostility that measure negative interpersonal reactions and
CVR correlates have not been adequately studied.
In summary, the majority of the studies of anger and CVR were descriptive
and correlational with small effect sizes. Two thirds of the studies used wellknown and reliable instruments, however interpretation of results was limited by
inadequate definitions and distinctions between the constructs of anger and
hostility. Most of the studies used convenience samples of college students and
were further limited by inadequate samples of women and minorities. However,
ten large prospective studies used community samples with some reporting
significant correlations between anger and other psychosocial factors,
hypertension, CHD and carotid atherosclerosis. These results provide good
evidence for the anger-CVR connection.
Research on Inflammatory and Immunological Responses to Anger
Research examining immunological relationships and anger are meager
and have been mostly examined within the context of the role of inflammation as
a precursor to CHD. However, the findings from these studies tend to indicate
that an angry emotional state has an effect on changes in natural killer (NK) cells,
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natural killer cell activity (NKCA), and CRP. The negative impact on inflammatory
and immune responses provide further support for the role of atherogenesis in
the development of CHD.
Mills, Dimsdale, Nelesen, and Dillon (1996) seeking possible relationships
between CVR and immune reactivity, looked at the connection between anxiety,
anger expression, hostility, and enumerative immune responses to a 6-minute
laboratory speech stressor in 104 healthy community volunteers. Citing prior
research that had found stress, depression, and interpersonal conflict to be
associated with long-term immune dysfunction, and daily hassles associated with
short-term immunological changes, Mills et al. measured acute immune reactions
by videotaping subjects’ oral defense against a false accusation of shoplifting.
Pre- and post-speaking biochemical and psychological measurements were
obtained to determine the effects of the speaking stressor on the various cell
populations. Multiple linear regressions were analyzed to determine factors
associated with cellular responses and psychological characteristics, accounting
for age and smoking status. Leukocyte populations were analyzed via flow
cytometry and quantified by total white blood cell count, lymphocyte subsets, and
NK cells. NK cells are a class of lymphocytes that attack and kill malignant cells,
foreign cells, and virally infected cells.
Moderate but statistically significant (p<.03) associations between NK cell
responses and anger expression suggested that persons who expressed angry
emotions had lower increases in immune response compared to individuals
identified as hostile with higher numbers of NK cells (p=.02).
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Suppressor/cytotoxic cell increases were related to pre- and post-anxiety scores
with those reporting the greatest amount of chronic stress showing the smallest
acute increases in WBC (p=.006). Overall, these findings suggested that certain
emotional responses or personality characteristics, like anger and hostility, may
be associated with short-term immune function changes, similar to CVR
responses, reinforcing the PNI connection (Mills et al., 1996).
Larson, Ader, and Moynihan (2001) also employed an acute laboratory
stressor to identify correlates of neuroendocrine, immune, and CVR responses
by examining stress-related changes in NKCA, cortisol, and cytokines that elicit
macrophage and antibody activity, interferon gamma (IFN-g), and interleukin-10
(IL-10) in 56 healthy subjects. Heart rate, blood pressure, and blood samples
were obtained 30 minutes before, during, and immediately after a stress-inducing
speech task in which subjects were asked to describe their best and worst
characteristics. Additionally, they were under the assumption that they were
being evaluated by psychologists to determine how persuasive each subject’s
speech was compared to each other. As expected, increased CVR was seen all
subjects and 91% showed significant increases in NKCA (p<.001); 69% showed
significant IFN-" increases (p<.009). NKCA was found to be significantly and
positively correlated with CVR (p<.004). Anger suppression was also found to be
significantly and positively correlated with CVR (p<.02), cortisol (p<.007) and IL10 (p<.02). Of note, the use of almost 40 regression equations at a significance
level of p<.05 likely led to some spurious findings. However, the hypothesis that
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increased anger suppression as a psychological risk factor for increased CVR
and lowered altered immune response was supported.
An early PNI study examined how emotion contributes to immunologic
changes in response to psychological stress during marital conflict. Miller, Dop,
Myers, Stevens, and Fahey (1999) explored the idea that emotions induced by
naturalistic stressors would also elicit stress-induced changes in immune
parameters. They hypothesized that spouses would respond with negative
emotions to an episode of marital conflict and these responses could be
measured by increases in blood pressure, heart rate, circulating catecholamines,
and increases in NK cells, NKCA, and CD8 T-lymphocytes. Further, they sought
to determine if the relationship between anger and physiological changes was
moderated by hostility. Married couples (n=113) were extensively screened to
reduce confounders that might be produced by pre-existing medical, social, and
lifestyle conditions. From this pool, 41 couples completed a marital problem
inventory and several psychological scales prior to having blood samples and
biological measurements taken. Based on their responses to the marital problem
inventory, the researchers suggested a topic (such as household management or
communication) that had been identified by both spouses as a source of conflict.
During a 15-minute videotaped problem-solving discussion, several blood
samples, heart rate, and blood pressure measures were taken, concluding with a
final sample taken after a 25-minute rest period at the end of each couple’s
session. Emotional affect scores were also developed by trained observers who
assigned one of nine emotion codes to each subject for every 5-second interval
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of discussion. Scores were used to compute a series of correlations between
affect scores and reactivity and recovery scores for each of the physical
parameters.
Controlling for baseline physiological values, partial correlations revealed
that high levels of husbands’ affective anger covaried with greater systolic blood
pressure increases (p<.01) but wives’ anger did not. Affective anger scores for
both genders were unrelated to neuroendocrine and immune parameters during
and after conflict discussion. Husbands who scored high on hostility showed
significantly greater increases in NKCA during discussion and less recovery
response (p<.01). Also, higher levels of anger covaried with greater increases in
NK cell numbers during discussion (p<.05) but were unrelated to recovery. No
significant findings were found in any parameters for wives. In general, men high
in cynical hostility displayed more anger during conflict and had greater increases
in heart rate, blood pressure, cortisol, NK cells, and NKCA.
The lack of similar findings in women in this observational design was
thought to be possibly related to the differences in the more pronounced
testosterone secretion elicited in men during anger expression. Perhaps, as
pointed out by Abel et al. (1995), the overall differences in anger expression
among men and women affected how emotion coding was recorded in that what
may have been an angry response by a wife was coded as dissatisfaction or
sadness, rather than anger. Further, the large number of statistical comparisons
likely produced some correlations that were actually due to chance.
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A naturalistic stress design was used to study lymphocyte proliferation in
spousal caregivers of persons with Alzheimer’s disease (Scanlan, Vitaliano,
Zhang, Savage, & Ochs, 2001). Dyads of 82 spouse caregivers of patients with
Alzheimer’s and 83 age- and gender-matched spouses of normal controls were
included in the final analysis of carefully screened volunteers. Extensive inclusion
and exclusion criteria, as well as psychiatric and medical confirmations of a
diagnosis of Alzheimer’s disease in the absence of all other neurological,
cardiovascular, and immune related diseases, medications, psychological
disorders, etc., supported this repeated-measures design to eliminate as many
confounding variables as possible.
Participants completed several psychological instruments which were
correlated to lymphocyte proliferation responses to mitogens. Mitogens are
agents that induce in vitro mitosis and are considered a reliable measure of
immune system function in depressed subjects (Vedhara & Irwin, 2005). For
anger-related measurements, in all cases and both times, no statistically
significant main effect of anger expression was found. However, anger
expression did significantly interact with caregiving status at Time 2 (but not at
Time 1) for all changes in lymphocyte production resulting in lower immune
responses (p<.05) and was negatively correlated in caregivers. Caregivers with
the highest levels of outward anger expression showed significantly lower
mitogen responses than those with controlled anger expression styles (p<.05).
The authors concluded that these results appeared to be consistent with
other findings (Mills et al., 1996) that suggest high degrees of anger expression
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and/or hostility may be the anger components most likely associated with
negative health outcomes as a result of decreased immune response. However,
since stress-related hormones (cortisol and catecholamines) may also mediate
relationships of depression and anger with lymphocytic proliferation, lengthier
longitudinal studies are needed to determine if altered immune responses result
from anger or depression alone or the synergistic effect of both emotions.
Suarez (2003) examined the relationship of IL-6 to anger, hostility, and
depression as a function of multivitamin (MVI) supplement use in 96 healthy,
non-smoking men. Based on studies that reported daily use of antioxidants
and/or MVIs had been linked to reduced morbidity and mortality from
cardiovascular disease, Suarez hypothesized that anger, hostility, and severity of
depressive symptoms independently and as a composite psychological risk
factor score, would be positively associated with IL-6 among non-MVI users
compared to those taking MVIs. Following collection of blood samples, subjects
completed depression, hostility, and personality inventories which were then
used to generate a composite psychological risk score. Serial multiple regression
analysis was used to test the combined psychological risk factor score with MVI
use on IL-6 levels. IL-6 levels were significantly and independently positively
correlated with all psychological measures including the composite score (p<.05)
with the exception of the personality inventory (p<.10) in the non-MVI users;
significant correlations were not found for these same associations in the MVI
users. The individual instruments were significantly and positively intercorrelated
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(p<.01), providing support for their use of a composite psychological risk factor
score.
These findings suggest that significant associations between IL-6 and
psychological risk factors were moderated by the use of MVI supplements among
healthy men, especially those who might have a propensity to exhibit anger
and/or hostility. Limitations included the lack of testing for differences in health
behaviors in the high and low psychosocial risk factor groups as well as the
comparison of traditional risk factors for CHD (body mass index, resting blood
pressure, cholesterol, etc.), serum vitamin levels, and testing of only male
subjects.
Based on studies looking at recognized psychosocial risk factors for CHD,
such as poverty and depression that are known to increase TNF!, Suarez,
Lewis, and Kahn (2002) proposed that anxiety, hostility, and anger would be
associated with increased TNF! secretion in lipopolysaccharide stimulated
cultures and would also be identified as additional psychosocial risk factors for
CHD. Lipopolysaccharide (LPS) is a natural endotoxin released by Gram
negative bacteria which powerfully and non-specifically stimulates immune
responses in vitro. Subjects were 62 healthy, non-smoking males who completed
a psychological inventory that included a 5-item anger subscale prior to analysis
of LPS-stimulated blood samples for TNF! expression. Parallel multiple
regression models supported their hypothesis and showed significant positive
correlations between total anxiety, hostility, and anger scores and
TNF! expression (p=.007). Limitations included the constricted focus of anger in
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the psychological inventory that was used and that depression, which has also
been associated with increased TNF! expression, was not measured in this
study. Therefore, since the unique and combined relationships of psychological
risk factors of CHD such as depression, anger, hostility, and aggression also
affect inflammatory responses (Everson-Rose & Lewis, 2005), these results
should be interpreted with caution.
Suarez, Lewis, Krishnan, and Young (2004) conducted a study of hostility
and depressive symptoms in 44 women to determine if LPS-stimulation of
monocytes was correlated in a similar fashion as in men. Healthy, non-smoking,
premenopausal women were recruited and screened for medical and
psychological conditions that could alter monocyte marker expression (e.g. oral
contraceptives). Separate and combined effects of hostility and depression were
examined on the capacity of blood monocyte expression of IL-1, interleukin-8 (IL8), TNF!, and monocyte chemotactic protein, which stimulates up-regulation of
cellular adhesion molecules on endothelial cells, leukocytes, and platelets.
Separate depression inventory and hostility scales were used to assess
psychological symptoms and scores were compared individually and as a
composite psychological risk factor score. Multiple regression formulas were
used to look at BMI, total cholesterol, race, alcohol, 17b estradiol, and
progesterone levels as covariates. In contrast to their earlier study (see above),
anger expression was not measured, yet results for this study were reported as
similar. Hostility and depression scores, but not psychological risk factor scores,
were associated with greater general expression of proinflammatory cytokines
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(p<.05). Significant results were also noted when all scores were used to predict
LPS-stimulated expressions (p<.05). However, there were enough variances by
level of hostility and severity of depressive symptoms in that some cytokines
were up-regulated and others were not. Hostility enhanced expression of IL-1
and IL-8, while depression was associated with increased expression of TNF!
and IL-8 but not IL-1. Therefore, conclusions based on the general directions of
the associations using a psychological risk factor score and causality could not
be made.
Hapuarachchi, Chalmers, Winefield, and Blake-Whitemore, (2003)
measured homocysteine, CRP, salivary immunoglobulin-A (IgA), and lymphocytic
5’ectonucleotidase (NT) using a theoretical model that psychological stress is
associated with a pro-inflammatory state as a result of increased lymphocyte
mobilization and subsequent higher cellular oxidative stress. Lymphocytic NT is
a lymphocytic maturation marker and has been found to have a lower activity
level in decreased immunity states and is a measure of oxidative stress.
Oxidative processes produce free radicals which damage cells and initiate
inflammatory reactions.
Forty three participants volunteered blood and saliva samples and
completed various psychometric questionnaires, including an anger expression
scale. Correlation analysis was used to examine the strength of the relationships
between psychological and biochemical parameters. CRP was significantly and
positively correlated with outward expression of anger and anger experience
(p<.05) and significantly negatively correlated with anger control (p<.05). These
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findings may indicate that a pro-inflammatory state is associated with
unmanaged anger expression while a cognitive anger coping style was not.
Limitations included the use of a cross-sectional design that mostly relied on
correlational analysis and therefore causality cannot be implied. Additionally, the
authors acknowledge the subjects’ individual cognitive perceptions of overall
stress and the stress-illness process are multifactorial and complex. Also, other
variables could be confounding the results.
The relationship of psychological factors that influence the immune system
and accelerate the progress of CHD was explored by Ishihara, Makita, Imai,
Hashimoto, and Nohara (2003) who focused on anger expression. Known CHD
subjects were matched with healthy controls and measurements of NKCA were
analyzed against anger expression scores. In the CHD group, NKCA was found
to be significantly elevated (p<.05) by the suppression of anger and negative
emotions. Since this study was not prospective, the researchers were uncertain
whether the development of CHD or the power of psychological factors
influenced the immune response and promoted CHD. Additionally, the lack of
concomitant measurements of T-lymphocytes and cytokines limited any
implications of causation. Ishihara et al. speculated, based on this study and
earlier studies referenced in their findings, that emotional states such as anger
experienced in day-to-day living are the function of an acute psychological stress
response that up-regulates NKCA, and that suppression of anger is an important
factor that increases NK cell numbers through enhanced sympathetic and
endocrine system responses.
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Gouin, Kiecolt-Glaser, Malarkey, and Glaser (2008) recently published
their findings related to patterns of anger expression on wound healing. They
proposed that outward and inward expression of anger and lack of anger control
would be associated with delayed healing of standardized blister wounds. The
Anger Expression Scale of the STAXI-2 was administered (along with five other
psychological questionnaires) to 98 (40 men and 58 women) community-dwelling
subjects who were part of a larger study of the effects of relaxation on wound
healing. Salivary cortisol and IL-1a IL-1b IL-6, IL-8, and TNF! were examined in
both the relaxation intervention group and the control group over an eight-day
period.
The rate of healing did not differ between groups and no significant
differences were found in anger expression, however, results showed that higher
levels of anger control were associated with a higher level of wound healing at
day four (r=.45, p=<.01) even after differences in hostility, negative affect, sleep,
exercise, etc., were controlled. Anger out and anger in separately were not
related to speed of healing. Overall, individuals displaying less anger control
secreted more cortisol (but not cytokines, which were measured at the wound
site). This was the first study showing that anger dysregulation may delay
healing.
Summary of Review of Literature
To summarize, research studies examining immunological relationships
and anger are meager and have been mostly examined within the context of the
role of inflammation as a precursor to CHD. As noted earlier, anger and
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cardiovascular reactivity have been extensively studied and measured with
various instruments relative to risk of CHD, hypertension, and stroke revealing
both positive and negative associations. The cited PNI studies tend to indicate
that an angry emotional state may affect changes in NK, NKCA, CRP, and some
cytokines, contributing to the negative impact of inflammatory and immune
responses which further contribute to atherogenesis and the development of
CHD.
The majority of these studies were done on young, healthy, primarily male
populations with the use of multiple psychometric or psychological scales that
were subjected to extensive correlational analyses. Other studies used principal
components analysis to generate a composite personality factor score that may
not truly represent anger trait as a personality characteristic. The primary use of
correlational analysis in cross-sectional designs, especially with numerous
instruments, contributes to loss of statistical power and increases the likelihood
of spurious findings. Limited reports of repeated measures and prospective
designs greatly limit interpretation of data from this review.
Further, the blurring of the constructs of anger, hostility, and aggression,
and use of anger subscales from larger hostility, anxiety, depression, and other
psychosocial and personality instruments, as well as the lack of clarity in
describing anger expression, anger control/suppression, and other
characteristics of anger style, have made interpretation and generalizability of
research findings difficult. As Spielberger et al. (1985) pointed out over 20 years
ago, definitions for anger used in research instruments are often inconsistent and
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ambiguous. Most studies made use of self-report anger subscales of hostility,
anxiety, aggression, and depression inventories; few used only unique anger
expression scales, and only two studies measured anger trait as a separate
personality variable.
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Chapter Three: Methodology
Study Design, Setting, and Sample
A quantitative, cross-sectional between-groups design was used to
examine differences in CRP between high and low anger groups. The researcher
completed administration of all research instruments and questionnaires
exclusively. Participants who met the inclusionary/exclusionary criteria as
determined by the researcher were tested individually in a reserved private room
in the student health center at Florida Gulf Coast University in Ft. Myers, Florida.
All procedures were reviewed and approved by the Florida Gulf Coast University
and the University of South Florida (USF) Institutional Review Board (IRB#
106379D) and conducted according to protocols outlined by the USF Human
Research Protections Program.
The study was conducted on a convenience sample of healthy
community-dwelling women recruited from an urban college campus in
southwest Florida. Participants were recruited through announcements
(Appendix A) and networking to faculty, staff, and women’s groups, via
electronic mail, and recruitment posters placed in common areas, such as
the SHC, cafeteria, student union, and library. Men were excluded because
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women have been understudied in research examining anger and
cardiovascular disease risk (Abel et al., 1995; Kielcolt-Glaser, McGuire,
Robles, & Glaser, 2002).
Eligible women were between the ages of 45 and 65 and either postmenopausal or post-hysterectomy. Women under the age of 45 were excluded
because CHD normally develops during middle age. Women who were still
experiencing menses were excluded to control for the effect of endogenous
hormone levels. To insure a healthy sample, participants were non-smokers, not
on any hormone contraceptives or hormone replacement therapy, had no history
of any cardiovascular diseases (CHD, congestive heart failure, transient ischemic
attacks, stroke, etc.), diabetes mellitus, autoimmune diseases, severe mental
illness, or recent (90 days) history of acute infection, trauma, major surgery, or
other inflammatory conditions such as chronic bronchitis, gastric inflammation,
chronic renal disease, or recent (10 day) history of minor surgery. Participants
who were taking medications that are known to confound PNI studies
(cholesterol-lowering agents, prescribed non-steroidal anti-inflammatory drugs,
cortisone, prednisone, and other steroid preparations, large doses [more than
650 mg] of aspirin, etc.) were also excluded (Zeller, McCain, McCann, Swanson,
& Colletti, 1996). Participants who smoked cigarettes and/or used recreational
drugs, or drank more than two alcoholic beverages daily were excluded as these
substances are also known to increase CRP independently (Zeller).
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Procedures
Women who either called or emailed in response to recruitment
announcements were told that the total time to complete the initial study
instruments (which would determine whether they qualified for the rest of the
study) would take less than 10 minutes and if they were suited for the study, an
additional 15 to 20 minutes would be needed to complete the second part of the
questionnaire, and an additional 5 minutes to obtain their waist measurement
and a sample of their blood. Women who agreed to volunteer for the study were
given an appointment to meet with the researcher at which time further
information was provided regarding the risks and benefits of participating in the
second part of the study, particularly in relation to the need for providing a blood
sample. Women were told they might feel slight discomfort from having a needle
poked into their vein and that there might be a small chance of a bruise at the
place where the sample was taken.
Women were informed they would need to provide personal information
about their age, race/ethnicity, marital status, and years of education. Women
were assured that their personal information would be kept confidential by the
researcher and numerically coded to prevent any association between their
biographical information and their scores on the various research instruments,
waist measurements, and blood samples. Participants were reminded that their
inclusion in the study was voluntary and they could withdraw from the study at
any time, for any reason without any adverse effects to their status as a member
of the community.
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Following completion of the verbal explanation of the study, the
investigator reviewed the written informed consent form (Appendix B) with each
woman. After answering any questions posed by the subject, women were asked
to read and sign the informed consent form. Subjects then completed a
researcher-designed questionnaire (Appendix C) to verify study inclusion criteria
were met and were assigned a unique identification number. Next, qualifying
participants were asked to complete the biographical data section of the StateTrait Anger Expression Inventory-2 (STAXI-2) and provide information about their
age, race/ethnicity, marital status, and years of education (Appendix D). Next,
subjects were asked to complete the Trait Anger subscale of the STAXI-2. Upon
completion of the subscale, the researcher immediately tallied each subjects’
responses and those women who scored in the uppermost quartile (high anger)
and lowest quartile (low anger) of the trait anger subscale (as determined by the
age-matched normative groups provided in the STAXI-2 Professional Manual
[Psychological Assessment Resources, 1999]) were then asked to complete the
Anger Expression subscale of the STAXI-2. Women who failed to score in either
quartile were thanked for their time and excused.
Because there is a strong relationship (r>.35) between waist
circumference and CRP (Festa et al., 2001), immediately following completion of
the STAXI-2, the researcher measured and recorded the subject’s waist
circumference using a cloth measuring tape placed at the top of the iliac crests
and around the umbilicus.

38

Finally, using universal precautions, a licensed practical nurse obtained a
5 millimeter blood sample from each subject via antecubital venipuncture into
serum separator tubes and immediately refrigerated at 5º C. Subjects were
offered a $10.00 cash payment and thanked for their participation.
Within 24 hours of collection, the researcher spun the tubes in a cold
centrifuge at 3800 rpm for 25 minutes. Serum was immediately aliquoted and
frozen at -80º C until retrieved for analysis. Under the direct supervision of the
researcher’s chairperson in the University of South Florida College of Nursing
Biobehavioral Laboratory, serum was defrosted at room temperature and
prepared for measurement by the researcher using a high-sensitivity enzymelinked immunosorbent assay (ELISA). Serum was diluted 1:100 for the assay.
The assay uses unique polystyrene-coated monoclonal antibodies to CRP
which in the presence of CRP agglutinate causing an increase in the intensity of
scattered light which can be measured spectrophotometrically. The increase in
scattered light is directly proportional to the amount of CRP in the sample.
Subject serum samples, reference standards, and control serum samples
were prepared in duplicate exactly according to assay procedure protocol (DRG
International, 2005) and measured using a plate reader at 450 nm. A standard
curve was produced plotting the mean absorbance obtained for each reference
standard against its CRP concentration in mg/l with absorbance on the vertical
axis and concentration on the horizontal access. Data reduction was
accomplished by GraphPad Prism and obtained values of subject samples were
multiplied by 100 to obtain CRP results in mg/l.
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The assay range was 0.63 mg/l to 119.3 mg/l. Expected values for adult
serum range between 0.068 to 8.2 mg/l. Intra-assay coefficient variations ranged
from 2.3 to 7.5% and inter-assay coefficient variations ranged from 2.5 to 4.1%.
Assessment of Trait Anger and Anger Expression
Trait anger and anger expression were measured using the STAXI-2. The
STAXI-2 is a 57-item, two-part self-report questionnaire that assesses the
experience, expression, and control of anger on six major scales and five
subscales. The STAXI-2 measures State Anger, Trait Anger, Anger-In, AngerOut, and Anger Control. A composite Anger Expression Index is calculated from
the combined Anger-In, Anger-Out, and Anger Control subscales and is
computed to determine the overall level of anger expression with higher scores
indicating greater levels of overall anger expression (Spielberger, 1999). Table 2
describes the subscales used for this study.

40

Table 2.
STAXI-2 Subscale Descriptions
STAXI-2
Subscale
Trait Anger

No. of
items &
Score
Range
10
10 - 40

Anger
ExpressionOut

8
8 - 32

Anger
Expression-In
Anger
Control-Out
Anger
Control-In

8
8 - 32
8
8 - 32
8
8 - 32

Measurement
Differences in anger
proneness as a personality
trait or general tendency of
a person to get angry
Frequency of angry feelings
expressed in verbally or
physically aggressive
behavior
Frequency of angry feelings
that are experience that are
held in or suppressed
Frequency of controlling
outward expression of
angry feelings
Frequency of controlling
angry feelings by calming
down or cooling off

Example
“I am a hot-headed
person.” “When I do a
good job and get a poor
evaluation, I feel furious.”
“When angry or furious, I
slam doors…argue with
others…say nasty things.”
“When angry or furious, I
boil inside but don’t show
it.”
“I strike out at whatever
infuriates me.”
“I control my urge to
express my angry
feelings.”

The internal consistency of the STAXI-2 scales and subscales for normal
adults (n=1,572) are high as measured by alpha coefficients and range from .76
to .93 for females and .72 to .94 for males. The STAXI-2 takes approximately 1520 minutes to complete and requires a sixth grade reading level or below
(Spielberger).
Statistical Analysis
Data was analyzed using SPSS Version 16.0. Preliminary analysis was
conducted to examine the accuracy of data entry, missing values, outliers, and
normality. Next, descriptive statistics for all variables for both high and low anger
groups were determined. Variables were reported as means + standard
deviation.
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Next, differences in mean levels of CRP in women who were classified as
high trait anger were compared to those classified as low trait anger and those
classified as high expression anger compared to women who were in the low
expression anger group. To determine the effect of group membership on CRP,
an independent t-statistic compared the computed value to the critical value of t
based on 40 degrees of freedom (df = nHIGH + nLow – 2).
Finally, Pearson associations of bivariate correlation coefficients between
the anger variables and CRP and other continuous variables were examined. All
statistical testing was conducted with a p <0.05 level of significance.
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Chapter Four: Results
Descriptive Statistics
An initial cohort of 79 women met inclusion and exclusion criteria and led
to the final 42-woman sample of 45 to 65 year-old post-menopausal women.
Based on the STAXI-2 Trait Anger Subscale reference quartiles provided by
Spielberger (1999) for females 30 and older, women were qualified for the low
trait anger group (n=25) if their STAXI-2 trait subscale score was 14 or less or the
high trait anger group (n=17) if their score was 21 or greater. Descriptive
statistics for the cohort, sample, and trait groups are summarized in Table 3 and
described below.
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Table 3.
Descriptive Statistics of Cohort, Sample, and Trait Groups
Cohort
n=79

Variable

Age, mean years

Race/Ethnicity

Marital Status

Sample
n=42

High
Trait
n=17

Low
Trait
n=25

55.87

55.81

54.35

56.80

69
(87%)

36
(86%)

16
(94%)

20
(80%)

9 (11%)

6 (14%)

1(6%)

5 (20%)

Hispanic

1 (1%)

0

0

0

Married

58
(73%)

29
(69%)

13
(76%)

16
(64%)

Unmarried

21
(27%)

13
(31%)

4 (24%)

9 (36%)

16.40

16.12

15.80

16.40

17.00

17.00

23.71

12.44

30.10

41.59

22.28

33.27

33.00

33.50

2.74

2.69

2.77

Caucasian
AfricanAmerican

Education, mean
years
Anger Trait Score,
mean
Anger Expression
Index, Score, mean
Waist Circumference,
mean inches
CRP, mean mg/L

The average age for the cohort, sample, and trait anger groups were
similar with mean values of 55.87 (+ 5.01) years for the cohort, 55.81 (+ 4.68 SD)
years for the sample, 54.35 (+5.16) years for the high trait group, and 56.80
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(+4.14) years for the low trait group. Caucasian women made up 87% (n=69) of
the cohort. Of the remaining ten women, 11% were African-American (n=9), and
1% (n=1) Hispanic. The study sample was 86% Caucasian (n=36) and 14%
(n=6) African American. Of the high trait group, 94% (n=16) were Caucasian,
with the remaining six percent (n=1) African-American. In the low trait group, 80%
(n=20) were Caucasian and 20% (n=5) were African-Americans.
Of the cohort, 73% (n=58) were married and 27% (n=21) were unmarried
(single, widowed, divorced, or separated). Of the study sample, 69% (n= 29)
were married and 31% (n=13) were unmarried. In the high trait group, 76%
(n=13) were married and 24% (n=4) were unmarried. In the low trait group, 64%
(n=16) of the women were married with the remaining 46% (n=9) unmarried.
The average years of education for the cohort was 16.40 (+ 5.01) years
with a range of 6 to >20 years. The average years of education for the study
sample was 16.12 (+3.43). The high trait group mean for years of education was
15.80 (+ 3.65) and the low trait group mean was 16.40 (+ 3.33). The average
waist circumference for the sample was 33.27 (+ 4.99) inches with a high trait
waist circumference average of 33.00 (+ 5.57) and a low trait mean waist
circumference of 33.50 inches (+ 4.66).
CRP results were positively skewed with the majority of the values at the
low end of the range (.07 – 8.93). The study sample mean was 2.74 (+2.19) for
the sample. The high trait group levels ranged from 0.33 to 7.71 with an average
of 2.69 (+2.15) and the low trait mean was 2.77 (+2.29) with a range of .07 to
8.93. Prior to data analysis, CRP values were transformed to their square roots
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and generated non-skewed transformed CRP values that were not statistically
different from those in a sample drawn from a theoretical normal distribution
according to the Shapiro-Wilks test for normality.
The average anger trait score for the cohort was 17.00 (+4.00) and ranged
from 10 to 30 which also represents the 50th percentile score for females 30
years and older (Spielberger, 1999). The trait score means of the high and low
trait anger groups were significantly different (t(40)=16.54, p <.001) between
groups. Cohen’s d was 2.62, which is considered a large effect size (Cohen,
1999). In this study, the groups’ means were > 2.5 SD from each other indicating
they were substantially different from each other in anger trait.
The average anger expression index was 30.10 (+14.66) with a range
from 7 to 62. The anger expression score means were also statistically significant
(t(40)=5.47, p=<.001) between the high and low trait groups. The groups’ mean
anger expression scores differed by <1 SD with a large effect size (d= .87) which
also supports the assumption that the two trait groups are substantially different
from each other in anger expression.
Mean CRP Differences between High and Low Trait Anger Women
The first research question asked whether there were statistically
significant differences in mean levels of CRP in women who were classified as
high trait anger compared to those classified as low trait anger. A directional
hypothesis was proposed that high trait anger women would have higher mean
levels of CRP compared to low trait anger women. An independent samples
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t-test statistic was calculated using the square root transformed CRP values and
failed to reject the null hypothesis (t(40)=0.13, p=.90, d= 0.02).
Mean CRP Differences between High and Low Anger Expression Women
The second research question asked whether there were statistically
different CRP values in women who had a high anger expression index score
compared to those who scored low in anger expression index. A directional
hypothesis was proposed that women who scored higher on anger expression
would have higher mean levels of CRP compared to low anger expression
women. An independent samples t-test statistic was calculated using the 50th
percentile anger index cut-off score of 29 (Spielberger, 1999) and the square root
transformed CRP values which failed to reject the null hypothesis (t(40)=.50,
p=.62).
Other Findings
Pearson product-moment correlation (PPMC) coefficients (r) were
assessed to determine if any variables were linearly related. As noted in Table 2,
results of the correlational analysis showed no statistically significant
associations between CRP and anger trait or anger expression scores. Waist
circumference was strongly and positively correlated with CRP (r = .48, p=.002).
CRP was found to be moderately and negatively associated with anger control-in
(r= -.34, p=.029). Although the relationship of CRP and anger control-out was not
significant (r= -.28, p= .07), a smaller negative association was also noted.
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Table 4.
Correlations among C-reactive protein, Waist Circumference, Anger Trait, Anger
Control, and Anger Expression
________________________________________________________________
Anger
Anger
Waist
Anger Control- ControlCircumference
Trait
Out
In
Expression Index
________________________________________________________________
C.473**
-.047
-.283
-.338*
.197
Reactive
.002
.767
.070
.029
.212
Protein
________________________________________________________________
*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
Figure 2 depicts the scatterplot between CRP and waist measurement and
indicates a linear relationship that as waist circumference increases, CRP levels
also increased. Scatterplots depicted in Figures 3 and 4 show that as scores on
the anger control in and anger control out increased, CRP levels decreased.
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Figure 2. Scatterplot of CRP and Waist Circumference.
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Figure 3. Scatterplot of CRP and Anger Control Out.
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Figure 4. Scatterplot of CRP and Anger Control In
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Chapter Five: Discussion
One third of women currently over the age of forty will develop CHD in
their lifetime. The roles of chronic and excessive inflammation are well-known
factors that contribute to atherogenesis and CHD. Less is known about how
stressful emotions, such as anger, are associated with proinflammatory
processes and how unhealthy anger expression styles might contribute to CHD
morbidity and mortality.
Anger is a strong and generally negative emotion that includes both the
felt emotion of anger and how anger is expressed or suppressed. Anger is also a
common stress response based on the association of a recurrent pattern of an
exaggerated sympathetic nervous system response. Research has shown how
the direct and indirect effects of both acute and chronic angry emotions
contribute to atherogenesis and subsequent CHD through increases in blood
pressure and heart rate (CVR), and inflammatory responses.
The review of literature for this study reports significant correlations
between anger, hypertension, CHD, premature death from CHD, and carotid
atherosclerosis and provide solid evidence for the anger-CVR-CHD connection.
Research examining immunological relationships and anger are meager and
were mostly examined within the context of the role of inflammation as a
precursor to CHD. Cited PNI studies seemed to indicate that anger may affect
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changes in NK, NKCA, CRP, and some cytokines with an overall negative impact
on inflammatory and immune responses.
In general, research to date has been limited by the use of convenience
samples of primarily male populations and the use of instruments that capture
more of the constructs of hostility, aggression, or anxiety rather than anger. Very
few studies related anger control to measureable cytokine levels, with most being
related to measures of CVR.
Discussion of Findings
The specific aims of this study were to compare differences in serum
levels of CRP in 45-65 year-old post-menopausal women who were classified as
either high or low anger trait. Mean CRP levels were not significantly related total
trait anger scores or total anger expression scores. There were strong and
positive correlations with waist circumference in that levels of CRP increased as
waist circumference increased. This linear association has been repeated in
multiple studies over many years and was not unexpected. The CRP-waist
circumference relationship replicated in this study is based on the well-known
role of excessive adipose tissue, particularly visceral fat in the abdominal area,
as key regulators of inflammation and a major source of pro-inflammatory
cytokines (Tracy, 2001; Yudkin, Humphries, & Mohamaed-Ali, 2000).
CRP levels were significantly inversely related to anger control-in scores;
as anger control-in scores increased, CRP levels decreased. This same inverse
relationship was also noted, although not statistically significant, between CRP
and anger-out scores.
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Exactly which components of anger trait and anger expression contribute
to positive health outcomes have been studied with mixed results (Hogan &
Linden, 2004; Thomas, 2007). The comparison of this study to previous research
is limited because only a handful of studies used the STAXI, STAXI-2, and/or
STAXI-2 subscales applying Spielberger’s (1999) definition of anger control-in
and anger control-out (see Table 2). As noted earlier, many studies used
questionnaires that actually measured hostility, anxiety, and negative mood, but
reported the results as anger trait and anger expression characteristics.
This study found that higher anger control, especially anger control-in was
associated with lower levels of CRP, a marker of inflammation. Anger control-in
is anger controlled through suppression, and the induction of calm and relaxation
at the moment an angry feeling arises. Persons with high anger control-in scores
tend to focus on calming down and reducing their anger as soon as possible.
High anger control-out scores indicate that a person spends a great deal of time
and energy in monitoring their outward expression and experience of anger. This
finding was consistent with two other studies that measured CRP with the STAXI2 reported in this paper (Gouin, et al, 2008; Hapuarachchi, et al., 2003).
Gouin et al. (2008) used the STAXI-2 and found no significant differences
in wound healing among high and low anger expressers, but did show that higher
levels of anger control were associated with a higher likelihood of faster healing.
Anger control predicted healing over and above differences in negative affect,
social support, and health behaviors. Perhaps anger control creates a beneficial
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physiological state that ameliorates the effects of stress on the inflammatory
process.
Hapuarachchi et al. (2003) found CRP levels to be significantly lower as
anger control scores increased although he did not differentiate between anger
control-in and anger control-out levels. He surmised that the use of productive
anger coping skills may provide physiological benefit. These findings are similar
to the results of this study, supporting the idea of health benefits through anger
control.
Although not measuring CRP, Ishihara et al. (2003) observed high values
of anger control significantly increased NK cell activity in CHD patients, but not in
normal controls. NK cytotoxic function is affected by positive emotions, in
general, and is an index of the ability of the immune system to kill viruses, cancer
cells, and foreign cells (Vedhara & Irwin, 2005). He speculated that this was likely
an over response related to anger experiences of daily life and was a function of
the acute neuroendocrine response rather than anger expression style. He
proposed that frequent exposure to anger provoking events could contribute to
chronic stress and downregulate the immune response.
Lawler et al. (1998) found high anger control correlated with lower levels
of systolic blood pressure in subjects with a family history of hypertension, and to
a lesser extent in those without a family history during an anger recall interview.
These results were attributed to increased awareness of CVR risk related to
family history and the conscious response to control anger expression styles
(calming down).

55

Williams’ et al. (2000) large prospective study revealed that over time,
healthy high anger trait individuals were three times as likely to be at risk for
cardiovascular events compared to their low anger trait counterparts. These
anger-prone persons, by their propensity to experience frequent high anger
arousal over long periods of time, are particularly likely to suffer
pathophysiological consequences related to chronic anger mismanagement.
As noted, research in this area is sparse, particularly related to measuring
immune variables in relation to anger control and anger expression styles and
health outcomes, particularly in women. Even less research has been done on
measuring these biomarkers after cognitive behavioral interventions have been
completed. Research on depression has shown a direct relationship between
depressive emotional states and stress induced immune activation, similar to an
acute phase response, where downregulation of the NK cell and T-cell-mediated
response might adversely affect health (Zorilla et al., 2001.)
Strengths and Limitations
A significant limitation to the study was the small sample size (N=42) and
unequal group sizes. The sample size was lower than the a priori calculation
requiring 26 women in each group for a total sample size of 52 which would have
been large enough to allow calculation of a large effect size with a power of
d=.80. The CRP levels of the sample study were generally low across groups.
For example, the overall sample mean was 2.74 mg/l. Normal levels are
considered to be below 3 mg/l with ranges of 0.3 to 6.6 mg/l (Ridker, 2004).
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This study consisted of post-menopausal, 45 to 65 year-old women who
had an average of 16 years of education, were mostly Caucasian and married.
The results of this study may not be generalizable to men, women of other age
groups, ethnicity, marital status, or educational level.
Because a convenience sample was used and women were offered a
cash payment to participate, selection bias is possible and may have influenced
the subjects. The subject questionnaire and the STAXI-2 were both self-report
measures. Since women knew the purpose of the study they may have
responded in a manner that would be more likely to include them in the study.
Although subjects were excluded if they reported a personal history of
CHD, diabetes, or other chronic diseases, a detailed health history was not
obtained and CRP levels may have been affected by the presence or absence of
unknown conditions that might trigger an inflammatory response.
Implications for Future Research and Practice
Psychosocial factors indirectly and directly affect the risk for and the
development of CHD. The extent to which anger and other negative emotions
contribute to sustained CRP production and dysregulation of the immune system
provides opportunity for early intervention. As women age and the prevalence
and incidence of women with CHD increases, research that identifies modifiable
psychosocial risk factors becomes increasingly important and can be examined
on both biological and psychosocial scales.
The theoretical framework of this study was based on the biopsychosocial
model of mind-body interactions (see Figure 1) and proposed high trait anger and
high anger expression responses may promote CHD. However, as pointed out by
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Thomas (2007) not all anger coping styles are unhealthy. Anger-discuss
describes talking about angry feelings with the provocateur or with a supportive
close friend. This type of anger control-out, whether a result of personal anger
coping strategies or anger management intervention strategies has been
associated with lower blood pressure (Abel et al., 1995; Hogan & Linden, 2004;
Thomas, 1997) and better glycemic control in diabetic subjects (Yi, Yi, Vitaliano,
& Weinger, 2008).
Given the accumulating evidence from large prospective studies that
anger influences the development of CHD (Williams et al., 2000), angry
temperament and exposure to chronic and repeated stressors sustain CVR, and
affect immune responses (Lovallo & Gerin, 2003), opportunity is created to
further research these intricate relationships. However, which components of
anger expression are more likely contribute to adverse health outcomes needs
further study since not all anger forms of anger expression are necessary
unhealthy.
For example, management of unhealthy anger expression styles might
contribute to downregulation of pro-inflammatory responses in women with
chronic diseases could also be evaluated for anger expression styles that may
negatively influence disease distress. Active anger coping activities (relaxation,
deep breathing) and cognitive anger management strategies could be taught to
provide women with positive ways to cope with the daily stressors inherent with
chronic diseases and minimize the deleterious effects of inflammatory responses
of acute and chronic stress responses to angry emotions.
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In conclusion, measuring PNI responses is a relative new science to
nursing. The measurement of proinflammatory biomarkers provides objective and
relatively accurate and precise measurements. Combined with in vivo (CVR) and
in vitro (cytokines) measurements, subjective dimensions of anger characteristics
provide opportunity to validate the health risks associated with stressful emotions
like acute and chronic anger. For example, a prospective study which included
the contributions of age, genetics, medical history, history of stressors, immune
activation, socioeconomic status, depression, perceived stress, and daily lifestyle
habits could examine the effect of stress reduction and positive anger coping
education on proinflammatory cytokines, including CRP, against anger trait and
expression scales and subscales over time to partial out the independent and
deleterious effects of unhealthy anger coping strategies. Repeating these
measurements following angry behavior modification could provide evidence of
the positive effects of anger control on heart health.
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Appendix A
Women Needed for a Research Study on Anger
!
!

!
!

Women between the ages of 45-65 who are post-menopausal or posthysterectomy are needed to be part of a confidential study about the emotion
of anger and a blood protein called CRP.
You will be asked to fill out a survey about how you experience anger. Based
on your survey score, you may be asked to complete the second part of the
study, have you waist measured, and provide a small sample of blood
obtained from your arm.
The entire study will take about 30-40 minutes and you will be offered $10 for
your time if you are eligible to complete both parts of the study.
The study will be completed confidentially in a private room.
You would not be eligible to participate in this study if you:

!
!
!
!
!
!

cannot speak or read English.
weigh less than 110 pounds.
smoke cigarettes, use drugs, or drink more than 2 alcoholic
beverages/day.
have a history of heart disease, stroke, diabetes, or autoimmune diseases.
taking cholesterol medications, hormones, or steroids.
have had major surgery, trauma, infection, or inflammation in the past 90
days.
If you would like to take part in this study, please contact Rosalyn Gross
239-590-7521 (office) or 239-564-2903 (cell) or rgross@fgcu.edu
Permission to conduct this study has been granted by the University of South
Florida Institutional Review Board and Florida Gulf Coast University
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Appendix: B
Rosalyn Gross: Dissertation
Informed Consent Minimal
Risk
Informed Consent to Participate in Research
Information to Consider Before Taking Part in this Research Study
Researchers at the University of South Florida (USF) and Florida Gulf Coast
University (FGCU) study many topics. To do this, we need the help of people
who agree to take part in a research study. This form tells you about this
research study.
We are asking you to take part in a research study that is called:
Relationship of Anger Trait and Anger Expression to C-Reactive Protein in PostMenopausal Women
The person who is in charge of this research study is Rosalyn Gross, MS, MSN,
APRN-BC.
The research will be done at FGCU.
Purpose of the study
The purpose of this study is to look at the differences in women’s anger and how
these differences are associated with a certain normal protein found in blood
called C - reactive protein or CRP.
Study Procedures
If you take part in this study, you will be asked to provide confidential personal
information about your age, race/ethnicity, whether you are married or unmarried,
and how many years of school you have completed. You will also be asked to
complete a short 10-item survey. Your score on the survey will be worked out
and if your score fits into one of two groups, you will then be asked to complete a
second survey of 32 questions, have your waist measured and provide a small
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amount (5 ml or about 1 teaspoon) of your blood that a licensed nurse will draw
from a vein in your arm through a sterile needle. The most amount of time you
will spend for both parts of the study will be no more than 40 minutes. The first
part of the study will take about 10 minutes; if you are asked to complete the
second part of the study, it will take an additional 20-30 minutes. You will only
have to be in the study one time. The study will take place in a private room at
the Florida Gulf Coast University Student Health Center. There will be no
audiotaping or videotaping of you or any of the study.
Alternatives
You have the alternative to choose not to participate in this research study.
Benefits
We don’t know if you will get any benefits by taking part in this study.
Risks or Discomfort
There following risks may occur:
•

There may be slight discomfort from having a needle poked through your
skin and into your vein while having a blood sample taken. There may be
a small chance that you will have some minor discomfort and/or bruising
at the place where the blood sample was taken. There may be a rare
chance that the skin around the area would get infected if it was not kept
clean immediately after your blood sample was drawn.

•

If you are a person who finds it hard to look at needles, syringes or their
own blood, you may feel dizzy or light-headed and would need to be
careful when standing up after the blood sample is drawn.

Compensation
We will pay you for the part of the time you volunteer while being in this study. If
you spend more than 10 minutes in the study you will be offered a $10 cash
payment.
Conflict of Interest Statement
None.
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Appendix B (continued)
Confidentiality
We must keep your study records confidential.
Information about your study records will be kept confidential and kept secure by the
researcher by labeling your record with a number and matched to your
information through an encoded computer database. Nobody other than the
researcher will have access to your study records.

However, certain people may need to see your study records. By law, anyone
who looks at your records must keep them completely confidential. The only
people who will be allowed to see these records are:
•

The research team, including the Principal Investigator and the licensed
nurse who draws your blood.

•

Certain government and university people who need to know more about
the study. For example, individuals who provide oversight on this study
may need to look at your records. This is done to make sure that we are
doing the study in the right way. They also need to make sure that we are
protecting your rights and your safety. These include:
•

the University of South Florida Institutional Review Board (IRB) and
the staff that work for the IRB. Other individuals who work for USF
that provide other kinds of oversight may also need to look at your
records.

•

the Florida Department of Health, people from the Food and Drug
Administration (FDA), and people from the Department of Health
and Human Services (DHHS).

We may publish what we learn from this study. If we do, we will not let anyone
know your name. We will not publish anything else that would let people know
who you are.
Voluntary Participation / Withdrawal
You should only take part in this study if you want to volunteer. You should not
feel that there is any pressure to take part in the study, to please the investigator
or the research staff. You are free to participate in this research or withdraw at
any time. There will be no penalty or loss of benefits you are entitled to receive if
you stop taking part in this study. Decision to participate or not to participate will
not affect your student, job, or professional status.

80

Appendix B (continued)
Questions, concerns, or complaints
If you have any questions, concerns or complaints about this study, call Rosalyn
Gross at 239-564-2903.
If you have questions about your rights, general questions, complaints, or issues
as a person taking part in this study, call the Division of Research Integrity and
Compliance of the University of South Florida at (813) 974-9343.
If you experience an adverse event or unanticipated problem, call Rosalyn Gross
at 239-564-2903.
Consent to Take Part in this Research Study
It is up to you to decide whether you want to take part in this study. If you want
to take part, please sign the form, if the following statements are true.
I freely give my consent to take part in this study. I understand that by
signing this form I am agreeing to take part in research. I have received a copy
of this form to take with me.
Signature of Person Taking Part in Study

Date

Printed Name of Person Taking Part in Study
Statement of Person Obtaining Informed Consent
I have carefully explained to the person taking part in the study what he or she
can expect.
I hereby certify that when this person signs this form, to the best of my
knowledge, he or she understands:
•

What the study is about.

•

What procedures/interventions/investigational drugs or devices will be
used.

•

What the potential benefits might be.

•

What the known risks might be.

I also certify that he or she does not have any problems that could make it hard
to understand what it means to take part in this research. This person speaks
the language that was used to explain this research.
This person reads well enough to understand this form or, if not, this person is
able to hear and understand when the form is read to him or her.
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This person does not have a medical/psychological problem that would
compromise comprehension and therefore makes it hard to understand what is
being explained and can, therefore, give informed consent.
This person is not taking drugs that may cloud their judgment or make it hard to
understand what is being explained and can, therefore, give informed consent.
____________
Signature of Person Obtaining Informed Consent
Printed Name of Person Obtaining Informed Consent
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Appendix C: Subject Screening Form
Are you between the ages of 45-65?

Yes

No

Are you postmenopausal or post hysterectomy?

Yes

No

Do you take hormone replacement therapy (pills/patches)?

Yes

No

Do you take medication to lower your cholesterol?

Yes

No

Do you take prescribed anti-inflammatory medication?

Yes

No

Do you take more than two aspirins daily?

Yes

No

Do you smoke?

Yes

No

Do you drink more than two alcoholic beverages daily?

Yes

No

In the past ten (10) days, have you had any minor surgery?

Yes

No

Hospitalization for major trauma, surgery or illness

Yes

No

Acute infection or inflammation

Yes

No

Coronary heart disease

Yes

No

Congestive heart failure

Yes

No

Cerebral vascular disease or stroke

Yes

No

Diabetes

Yes

No

Autoimmune disease (rheumatoid arthritis, lupus, etc.)

Yes

No

Chronic bronchitis

Yes

No

Chronic renal disease

Yes

No

Severe mental disease

Yes

No

In the past ninety (90) days, have you had any of the following?

Do you have or have you had any of the following conditions?
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